Horizon Oncology is a clinical research site located in Lafayette, Indiana, United States.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Horizon Oncology has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Healthy, Myelodysplastic Syndrome, MDS.
Sponsors: Endocyte, Astex Pharmaceuticals, Inc., Kyowa Kirin, Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Horizon Oncology has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Horizon Oncology has 5 clinical trials on record, with 1 currently active. Their work covers Healthy, Myelodysplastic Syndrome, MDS.
Yes — Horizon Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.